ArticleStem cell reports2017

Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.

Xiaohong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.